Effient launch poses puzzle for Lilly, Daiichi Sankyo
July 16 2009
Hoping to penetrate an anti-platelet market dominated for a decade by Plavix, Eli Lilly and Daiichi Sankyo received FDA approval ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.